PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-43.71%
Both yoy net incomes decline, with AVGO at -9.78%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-184.74%
Negative yoy working capital usage while AVGO is 18.76%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
40.78%
AR growth while AVGO is negative at -9.46%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-1950.00%
Negative yoy inventory while AVGO is 26.35%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-109.32%
Negative yoy usage while AVGO is 68.61%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
108.83%
Some yoy increase while AVGO is negative at -33.99%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-23.75%
Negative yoy CFO while AVGO is 7.23%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-7.59%
Both yoy lines negative, with AVGO at -44.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-0.41%
Negative yoy purchasing while AVGO stands at 45.71%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-36.40%
We reduce yoy sales while AVGO is 333.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-2323.33%
We reduce yoy invests while AVGO stands at 23.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-75.64%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-3.03%
Both yoy lines negative, with AVGO at -107.07%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.